AI monitoring with wearables for chronic heart failure
Part of Heart & circulation clinical trials.
This trial tests an AI system that uses wearable devices and mini-invasive tools to monitor people with chronic heart failure. The goal is to detect changes early and help manage the condition at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Had heart failure for at least 6 months
- On stable heart failure medicines for at least a month
- Any type of heart failure (reduced, mid-range, or preserved ejection fraction)
- Symptoms class I, II, or III (able to do daily activities with some limits)
- Had at least one hospital stay or urgent visit for heart failure in the past year that needed IV fluids or medicines
- Able to use a wearable device (patch, watch, or sensor) on your skin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether remote monitoring of your implanted heart device can help your doctors better manage your heart failure. It is for people with certain types of pacemakers or defibrillators who are willing to share their device data remotely.
This trial tests whether wearable devices (like smartwatches or phone apps) and artificial intelligence can help monitor your advanced heart failure. You may be more involved in your care by tracking your symptoms at home, and the information could help doctors act sooner if needed.
This trial tests whether checking in remotely (telemonitoring) helps doctors adjust heart failure medications more effectively. It is for people newly diagnosed with heart failure who have reduced pumping strength and signs of fluid buildup.
This trial tests whether using a smartwatch to monitor your heart at home can improve care for people who have atrial fibrillation (irregular heartbeat) and heart failure. It aims to make follow-up easier and catch problems early.
This study uses artificial intelligence to analyze heart ultrasounds from people hospitalized with heart failure. It aims to see if AI can help doctors better measure heart function and guide treatment.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
Hear when a new Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.